Piet van der Graaf, PharmD, PhD is Senior Vice President Applied BioSimulation at Certara, Professor of Systems Pharmacology at Leiden University, and Professor of Pediatrics at Cincinnati Children’s Hospital Medical Center. Previously, he was the Director of the Leiden Academic Centre for Drug Research and held leadership positions at Pfizer in Discovery Biology, DMPK and Clinical Pharmacology. CPTの創刊編集長であり、Pharmacometrics & Systems Pharmacology before becoming Editor-in-Chief of Clinical Pharmacology & Therapeutics. Pietはロンドン大学キングス・カレッジにてノーベル賞受賞者サー・ジェームズ・ブラックのもとで臨床医学の博士課程を修了し、He was awarded the 2024 Gary Neil Prize for Innovation in Drug Development from the American Society of Clinical Pharmacology and Therapeutics (ASCPT) and the 2021 Leadership Award from the International Society of Pharmacometrics (ISoP). 英国薬理学会のフェローに選出されており、これまで定量的薬理学および医薬品開発の分野にて250本以上の論文を発表しています。
Piet van der Graaf
Senior Vice President, Head of QSP
関連情報
Final ICH M15 Guidance: Aligning MIDD with Global Regulatory Expectations
ウェビナー
Start right, finish strong: Antibody-drug conjugate (ADC) studies for success
オンデマンド・ウェビナー
Strong starts, confident finishes: Optimizing first-in-human strategies for antibody–drug conjugates (ADCs)
ウェビナー
CHI ADC Webinar Series: From First-in-Human Dose Selection to Label Optimization, Commercial Expansion, and Market Access
ウェビナー
Virtual Triplets: The Next Step in Personalized and Ethical Drug Development
ブログ
